TG Therapeutics Inc (TGTX)

34.30 +0.06  +0.18% NASDAQ May 14, 16:59 USD
View Full Chart
Price Chart
View All TGTX News

News

View All Events

Events

Date Type Description
08/10/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/10/2021 08:30 Earnings Calls Q2 2021 Earnings Call
05/10/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/10/2021 08:30 EDT Earnings Calls Q1 2021 Earnings Call
03/02/2021 00:00 Earnings Results Q4 2020 Earnings Results
03/02/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
11/09/2020 00:00 Earnings Results Q3 2020 Earnings Results
08/10/2020 08:30 EDT Earnings Calls Q2 2020 Earnings Call
08/10/2020 00:00 Earnings Results Q2 2020 Earnings Results
06/18/2020 09:30 EDT AGM 2019 Annual General Meeting
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is developing two therapies targeting hematologic malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a unique epitope on the CD20 antigen found on mature B-lymphocytes. It is also developing TGR-1202 (umbralisib), an orally available PI3K delta inhibitor.
  • URL: https://www.tgtherapeutics.com
  • Investor Relations URL: https://ir.tgtherapeutics.com/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 10, 2021
  • Last Earnings Release: May. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
FIJYX Fidelity Advisor® Biotechnology Z 2.80%
FBIOX Fidelity® Select Biotechnology 1.73%
LADQX Lord Abbett Developing Growth R2 1.62%
LGLQX Lord Abbett Growth Leaders R2 1.41%
FSPHX Fidelity® Select Health Care 1.04%
FACTX Fidelity Advisor® Health Care M 1.04%
BTEC Principal Healthcare Innovators ETF 0.84%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.